Tegra Medical Announces New President/CEO

Tegra Medical is pleased to announce that Robert E. Pietrafesa has joined the company as President and Chief Executive Officer. Rob brings more than 16 years of experience as a President and Chief Operating Officer in medical device manufacturing; he has also held executive leadership positions in the clothing manufacturing and wholesale book industries. Most recently, Rob served as President of the InterV Division of Angiotech Pharmaceuticals after the successful sale of American Medical Instruments (AMI) to Angiotech for $785 million. During the three prior years, while he was President at the InterV Division of AMI, the firm’s revenues tripled and operating income increased by 500 percent. 

Tegra Medical is focused exclusively on the medical device industry, providing precision machining and contract manufacturing services. Tegra uses a wide range of manufacturing technologies to produce complex components and finished devices used in cutting-edge procedures for leading surgical, interventional and orthopaedic companies. (Source: Tegra Medical)

 

 

RELATED ARTICLES



CONTACT BONEZONE

 

CONTACT BONEZONE